68 related articles for article (PubMed ID: 16555430)
1. Clinical significance of multidrug resistance in AML: current insights.
Baer MR
Clin Adv Hematol Oncol; 2005 Dec; 3(12):910-2. PubMed ID: 16555430
[No Abstract] [Full Text] [Related]
2. Chemotherapy resistance in acute myeloid leukaemia.
Sonneveld P; List AF
Best Pract Res Clin Haematol; 2001 Mar; 14(1):211-33. PubMed ID: 11355932
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance in acute myeloid leukaemia.
Sonneveld P
Baillieres Clin Haematol; 1996 Mar; 9(1):185-203. PubMed ID: 8730557
[TBL] [Abstract][Full Text] [Related]
4. The sensitivity of human cells expressing RUNX1-RUNX1T1 to chemotherapeutic agents.
Tonks A; Pearn L; Mills KI; Burnett AK; Darley RL
Leukemia; 2006 Oct; 20(10):1883-5. PubMed ID: 16932340
[No Abstract] [Full Text] [Related]
5. Molecular characteristics therapy in AML.
Radich GP
Clin Adv Hematol Oncol; 2009 Jun; 7(6):11-4. PubMed ID: 19645131
[No Abstract] [Full Text] [Related]
6. Therapeutic significance of the tumor suppressor genes induced apoptosis for the reversal of multidrug resistance.
Kannan S
Med Hypotheses; 2006; 67(3):677-8. PubMed ID: 16725280
[No Abstract] [Full Text] [Related]
7. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
[TBL] [Abstract][Full Text] [Related]
9. Current and emerging strategies for the management of acute myeloid leukemia in the elderly.
Laubach J; Rao AV
Oncologist; 2008 Oct; 13(10):1097-108. PubMed ID: 18922830
[TBL] [Abstract][Full Text] [Related]
10. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.
van der Holt B; Van den Heuvel-Eibrink MM; Van Schaik RH; van der Heiden IP; Wiemer EA; Vossebeld PJ; Löwenberg B; Sonneveld P
Clin Pharmacol Ther; 2006 Nov; 80(5):427-39. PubMed ID: 17112800
[TBL] [Abstract][Full Text] [Related]
11. Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status.
Minderman H; Zhou Y; O'Loughlin KL; Baer MR
Cancer Chemother Pharmacol; 2007 Jul; 60(2):245-55. PubMed ID: 17096161
[TBL] [Abstract][Full Text] [Related]
12. [Selection of genes related to multidrug resistance of pancreatic ductal adenocarcinoma by microarray analysis].
Feng B; Zhao YP; Chen G; Zhang TP; Wu YD
Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(23):1629-33. PubMed ID: 18453221
[TBL] [Abstract][Full Text] [Related]
13. Resistance to chemotherapy in acute leukemia.
Löwenberg B; Sonneveld P
Curr Opin Oncol; 1998 Jan; 10(1):31-5. PubMed ID: 9466482
[TBL] [Abstract][Full Text] [Related]
14. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
[TBL] [Abstract][Full Text] [Related]
15. [Effects of transfection of antisense oligodeoxynucleotide of drug resistant genes by acoustic microbubbles and ultrasound mediating on multi-drug resistant hepatoma lines].
Jiang MD; Xiang TX; Peng ZP; Li SL; Yan Y; Wang ZH; Zhao Y; Huang XB; Fang L; Yang WY
Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):863-4. PubMed ID: 19032875
[No Abstract] [Full Text] [Related]
16. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
[TBL] [Abstract][Full Text] [Related]
17. Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients.
Malagola M; Damiani D; Martinelli G; Michelutti A; Cesana B; Vivo AD; Piccaluga PP; Ottaviani E; Candoni A; Geromin A; Tiribelli M; Fanin R; Testoni N; Lauria F; Bocchia M; Gobbi M; Pierri I; Zaccaria A; Zuffa E; Mazza P; Priccolo G; Gugliotta L; Bonini A; Visani G; Skert C; Bergonzi C; Roccaro AM; Filí C; Baccarani M; Russo D
Br J Haematol; 2007 Jan; 136(1):87-95. PubMed ID: 17222198
[TBL] [Abstract][Full Text] [Related]
18. [Take the study of mechanism of multi-drug tolerance in leukemia].
Hu YF; Zhou HH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1657-9. PubMed ID: 17825141
[No Abstract] [Full Text] [Related]
19. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
20. Childhood acute myelogenous leukaemia: association between PRAME, apoptosis- and MDR-related gene expression.
Goellner S; Steinbach D; Schenk T; Gruhn B; Zintl F; Ramsay E; Saluz HP
Eur J Cancer; 2006 Nov; 42(16):2807-14. PubMed ID: 16978861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
